TABLE 5.
Evaluation of results of two serologic methods for patients with CL and VLa
| Test and patient group (no. of patients) | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) | Agreement (%) | Kappa index |
|---|---|---|---|---|---|---|
| ELISA | ||||||
| CL (113) | 78.0 (64.8-91.0)b | 95.3 (78.7-100) | 97.8 (84.0-100) | 63.1 (48.0-78.1) | 83.3 (71.2-95.4) | 0.63 |
| VL (29) | 93.1 (74.7-100) | 95.3 (78.7-100) | 93.1 (74.7-100) | 95.3 (78.7-100) | 94.4 (79.8-100) | 0.89 |
| WB | ||||||
| CL (113) | 99.1 (86.0-100) | 72.1 (55.4-88.8) | 90.3 (77.5-100) | 96.9 (78.9-100) | 91.7 (79.6-100) | 0.77 |
| VL (29) | 100 (81.6-100) | 72.1 (55.4-88.8) | 70.7 (53.8-87.6) | 100 (82.0-100) | 83.3 (68.7-98.0) | 0.67 |
a
P was 0.00 for all comparisons.
b
The values in parentheses represent the 95% CIs.